George Zouridakis has potentially revolutionized how doctors and patients interact with skin cancer with his DermoScreen app. This mobile app ingeniously allows anyone to use their smartphone to take a photograph of an unusual looking piece of skin or mole and find out in seconds a diagnosis.
Zouridakis, professor of engineering technology at University of Houston, came up with the DermoScreen app as a solution to expensive skin cancer screenings offered by dermatologists and pathologists. The app uses a specially designed magnifying glass called a dermoscope to zoom in on potential problem area and snap a picture. Within seconds, the app will generate a diagnosis that has proven to be 85% accurate -- the same accuracy percentage of medical doctors.
What Makes This Trend Stand Out
- Mobile Dermoscopy
- The use of mobile apps and dermoscopes to enable non-experts to screen for skin cancer in seconds.
- Remote Diagnosis
- The ability for individuals to receive a quick and accurate diagnosis for skin cancer using their smartphones.
- Cost-effective Screening
- The disruption of expensive skin cancer screenings by offering affordable and accessible diagnostic tools through mobile apps.
Sectors Adopting This
- Healthcare
- The healthcare industry can incorporate mobile dermoscopy apps for efficient and cost-effective skin cancer screenings.
- Technology
- The technology sector can develop and improve mobile dermatology apps and dermoscope devices for accurate and remote skin cancer diagnoses.
- Telemedicine
- Telemedicine companies can integrate remote diagnosis features into their platforms, allowing individuals to receive immediate skin cancer screening results from anywhere.
